Neonatal Drug Development Education Modules

C-Path is proud to present its continuing education (CE) neonatal drug development modules — a collaboration between the International Neonatal Consortium (INC) and the National Association of Neonatal Nurses (NANN).

The decision to develop these modules stems from an INC multi-stakeholder survey aimed at exploring communication practices and stakeholders’ perceptions and knowledge regarding the conduct of clinical trials in the neonatal intensive care unit (NICU). The work was led by INC Communication Workgroup co-chair member Mary Short, MSN.

The goal of the modules is to provide foundational knowledge on innovative, regulated medicines development for neonates, including pipeline decision-making factors and addressing neonatal needs within the current environment. 

INC and NANN are providing the modules free of charge to nurses and other interested stakeholders; nurses completing the models will receive CE/contact hours.